IQV · News · 20260804N
Acquisition / Partnership / Divestiture
IQVIA HOLDINGS INC. · 2026-08-04 · Importance 31 · Surprise 42 · In source text
IQVIA announced a strategic collaboration with Medera Inc. to advance cardiac gene therapies and human-based drug discovery. IQVIA will contribute clinical-trial infrastructure, while Medera will contribute its gene-therapy platform and cardiovascular drug-development capabilities. The collaboration expands IQVIA’s involvement in gene therapy and innovative drug development without a disclosed transaction value. The partnership is intended to accelerate cardiac gene-therapy development and human-based discovery programs.
Key facts
- IQVIA and Medera Inc. announced a strategic collaboration to accelerate the development of cardiac gene therapies and human-based drug discovery. source
- Empowered Funds LLC increased its stake in IQVIA by 147.8% during the undefined quarter to own 19,519 shares after acquiring an additional 11,642 shares. source
- IQVIA and Medera announced the collaboration in a Business Wire release dated 2026-08-04. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | IQVIA and Medera Inc. announced a strategic collaboration to accelerate the development of cardiac gene therapies and human-based drug… |